Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine Augmentation in Bipolar Depression
NCT01528839Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of levothyroxine sodium in bipolar disorder (BD), sponsored by Charité – Universitätsmedizin Berlin. Started Mar 2004; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01528839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01528839.